Search Results - "FILETTI, S"

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Filetti, S, Durante, C, Hartl, D, Leboulleux, S, Locati, L D, Newbold, K, Papotti, M G, Berruti, A

Get full text

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer by Filetti, S., Durante, C., Hartl, D.M., Leboulleux, S., Locati, L.D., Newbold, K., Papotti, M.G., Berruti, A.

“…•This special article provides updated treatment recommendations on thyroid cancer.•New targeted systemic therapies have now been approved for treating…”
Get full text

Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach by Grani, G., Lamartina, L., Montesano, T., Maranghi, M., Filetti, S., Durante, C., Lopatriello, S.

“…Purpose Screening programs that target healthy populations are an important tool for identifying unrecognized, asymptomatic disease. However, ultrasound…”
Get full text

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism by Durante, C., Puxeddu, E., Ferretti, E., Morisi, R., Moretti, S., Bruno, R., Barbi, F., Avenia, N., Scipioni, A., Verrienti, A., Tosi, E., Cavaliere, A., Gulino, A., Filetti, S., Russo, D.

“…Context: BRAF mutations are common in papillary thyroid carcinomas (PTCs). By affecting the expression of genes critically related to the development and…”
Get full text

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial by Pratley, R, Nauck, M, Bailey, T, Montanya, E, Cuddihy, R, Filetti, S, Garber, A, Thomsen, A B, Hartvig, H, Davies, M

“…The aim of this study was to compare the efficacy and safety of once-daily human glucagon-like peptide-1 analogue liraglutide with dipeptidyl peptidase-4…”
Get more information

Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience by Mazziotti, G., Formenti, A. M., Panarotto, M. B., Arvat, E., Chiti, A., Cuocolo, A., Dottorini, M. E., Durante, C., Agate, L., Filetti, S., Felicetti, F., Filice, A., Pace, L., Pellegrino, T., Rodari, M., Salvatori, M., Tranfaglia, C., Versari, A., Viola, D., Frara, S., Berruti, A., Giustina, A., Giubbini, R.

“…Purpose and Patients The M.O.S.CA.TI. (Metastases of the Skeleton from CArcinoma of the ThyroId) is a multicenter, retrospective study investigating the…”
Get full text

The role of miR-139-5p in radioiodine-resistant thyroid cancer by Pecce, V., Sponziello, M., Verrienti, A., Grani, G., Abballe, L., Bini, S., Annunziata, S., Perotti, G., Salvatori, M., Zagaria, L., Maggisano, V., Russo, D., Filetti, S., Durante, C.

“…Purpose Radioiodine I-131 (RAI) is the therapy of choice for differentiated thyroid cancer (DTC). Between 5% and 15% of DTC patients become RAI refractory, due…”
Get full text

Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach by Falcone, R., Paci, P., Verrienti, A., Fiscon, G., Sponziello, M., Conte, F., Pecce, V., Rosignolo, F., Grani, G., Lamartina, L., Ramundo, V., Durante, C., Farina, L., Filetti, S.

Get full text

Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments by Grani, G., Tumino, D., Ramundo, V., Ciotti, L., Lomonaco, C., Armillotta, M., Falcone, R., Lucia, P., Maranghi, M., Filetti, S., Durante, C.

“…Purpose The aim of the study was to describe the spontaneous TSH level variations and levothyroxine dose adjustments in athyreotic patients with differentiated…”
Get full text

Notch Signaling Is Involved in Expression of Thyrocyte Differentiation Markers and Is Down-Regulated in Thyroid Tumors by Ferretti, E., Tosi, E., Po, A., Scipioni, A., Morisi, R., Espinola, M. S., Russo, D., Durante, C., Schlumberger, M., Screpanti, I., Filetti, S., Gulino, A.

“…Context: Notch genes encode receptors for a signaling pathway that regulates cell growth and differentiation in various contexts, but the role of Notch…”
Get full text

PB2279: REDUCED ABSOLUTE COUNT OF MONOCYTES IN PATIENTS CARRYING HEMATOLOGICAL NEOPLASMS AND SARS‐COV2 BREAKTHROUGH INFECTION by Romano, A., Conticello, C., Filetti, S., Bulla, A., Chiarenza, A., Del Fabro, V., Leotta, S., Markovic, U., Motta, G., Parisi, M., Stagno, F., Palumbo, G. A., Di Raimondo, F.

Get full text

Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo by Celano, M, Schenone, S, Cosco, D, Navarra, M, Puxeddu, E, Racanicchi, L, Brullo, C, Varano, E, Alcaro, S, Ferretti, E, Botta, G, Filetti, S, Fresta, M, Botta, M, Russo, D

“…In this study, we evaluated the activity of two novel pyrazolopyrimidine derivatives (Si 34 and Si 35) against ARO cells, a human anaplastic thyroid cancer…”
Get full text

Diagnostic, therapeutic and health-care management protocol in thyroid surgery: a position statement of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB) by Rosato, L., De Crea, C., Bellantone, R., Brandi, M. L., De Toma, G., Filetti, S., Miccoli, P., Pacini, F., Pelizzo, M. R., Pontecorvi, A., Avenia, N., De Pasquale, L., Chiofalo, M. G., Gurrado, A., Innaro, N., La Valle, G., Lombardi, C. P., Marini, P. L., Mondini, G., Mullineris, B., Pezzullo, L., Raffaelli, M., Testini, M., De Palma, M.

“…Purpose The diagnostic, therapeutic and health-care management protocol (Protocollo Gestionale Diagnostico-Terapeutico-Assistenziale, PDTA) by the Association…”
Get full text

Sodium/iodide symporter is expressed in the majority of seminomas and embryonal testicular carcinomas by Micali, S, Maggisano, V, Cesinaro, A, Celano, M, Territo, A, Reggiani Bonetti, L, Sponziello, M, Migaldi, M, Navarra, M, Bianchi, G, Filetti, S, Russo, D

“…Testicular cancer is the most frequent cancer in young men. The large majority of patients have a good prognosis, but in a small group of tumors, the current…”
Get full text

Cooperation of histone deacetylase inhibitors SAHA and valproic acid in promoting sodium/iodide symporter expression and function in rat Leydig testicular carcinoma cells by Maggisano, V., Puppin, C., Celano, M., D’Agostino, M., Sponziello, M., Micali, S., Navarra, M., Damante, G., Filetti, S., Russo, D.

“…The presence of the sodium/iodide symporter (NIS) is the prerequisite for the use of the radioiodine in the treatment of thyroid cancer. Thus, stimulators of…”
Get full text

Sodium/iodide symporter : a key transport system in thyroid cancer cell metabolism by FILETTI, S, BIDART, J.-M, ARTURI, F, CAILLOU, B, RUSSO, D, SCHLUMBERGER, M

“…The recent cloning of the gene encoding the sodium/iodide symporter (NIS) has enabled better characterization of the molecular mechanisms underlying iodide…”
Get full text

Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates by Morisi, R, Celano, M, Tosi, E, Schenone, S, Navarra, M, Ferretti, E, Costante, G, Durante, C, Botta, G, D'Agostino, M, Brullo, C, Filetti, S, Botta, M, Russo, D

“…There is no effective treatment for recurrent or metastatic medullary thyroid carcinoma (MTC), a tumor arising from thyroid C-cells commonly presenting an…”
Get full text

Na+/I symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues by LACROIX, Ludovic, MIAN, Caterina, CAILLOU, Bernard, TALBOT, Monique, FILETTI, Sebastiano, SCHLUMBERGER, Martin, BIDART, Jean-Michel

“…The expression of two recently identified iodide transporters, namely the sodium/iodide symporter (NIS) and pendrin, the product of the gene responsible for…”
Get full text

The ectonucleotide pyrophosphatase phosphodiesterase 1 ( ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals by Maranghi, M, Prudente, S, D’Erasmo, L, Morini, E, Ciociola, E, Coletta, P, Verrienti, A, Arciello, S, Copetti, M, Pellegrini, F, Santini, S.A, Morano, S, Filetti, S, Trischitta, V

“…Abstract Background and aims Several studies have reported that the ectonucleotide pyrophosphatase phosphodiesterase 1 ( ENPP1) K121Q polymorphism (rs1044498)…”
Get full text

Serological response to hepatitis B virus vaccine in HIV‐infected children in Tanzania by Pippi, F, Bracciale, L, Stolzuoli, L, Giaccherini, R, Montomoli, E, Gentile, C, Filetti, S, De Luca, A, Cellesi, C

“…Background HIV‐infected children have a lower seroconversion rate to hepatitis B virus (HBV) immunization than healthy children. Previous studies have produced…”
Get full text